http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005209335-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a8c9131f396e58c435adea58d43fe25 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-192 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 |
| filingDate | 2005-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3cf6f5006f8a0b44237b7890e50d1ae |
| publicationDate | 2005-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-2005209335-A1 |
| titleOfInvention | Methods for use of TARGRETIN in organ transplant rejection, autoimmune diseases and cancer |
| abstract | Methods are provided for treatment of graft versus host disease and other autoimmune diseases, organ transplant rejection, acute myeloid leukemia and T-cell non-Hodgkin's lymphoma other than cutaneous T-cell lymphoma in patients by administration of TARGRETIN. Also provided are methods for increasing neutrophil count and boosting the immune system of patients by administration of TARGRETIN and methods for enhancing efficacy of a cancer chemotherapeutic agent by co-administration of the cancer chemotherapeutic agent with TARGRETIN. |
| priorityDate | 2004-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 26.